News

Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery.

Arctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses

10 February 2021

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow

17 December 2020

Arctoris appoints three experienced industry executives as members of its Advisory Board

8 December 2020

Robot human handshake

Arctoris and Syntekabio form research partnership

8 September 2020

Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI

9 July 2020

Arctoris contributes its capabilities and expertise to the fight against COVID-19

7 July 2020

Arctoris launches BioTarget 2020 competition to support innovation in emerging biotech companies

21 February 2020

Arctoris announces partnership with Molecule to tackle the innovation crisis in drug discovery and development

10 February 2020

Arctoris successfully moves into its new global headquarters in Oxford, UK

11 December 2019

Arctoris strengthens senior team to continue the development of its on-demand drug discovery services

13 November 2019

Arctoris secures seed funding of £3.2 million to advance novel drug discovery platform powered by robotics

30 September 2019

Arctoris co-founder & CEO Martin-Immanuel Bittner features in a short film about reproducibility and open data in drug discovery

19 June 2019

BioTarget 2019 finalists compete in a pitch finale held in London, UK

11 June 2019

READY TO GET STARTED?

To find out how to accelerate your project timelines and generate higher quality data, reach out to us today.

Get in touch